These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
537 related items for PubMed ID: 22200553
41. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X, Zhao X. J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787 [Abstract] [Full Text] [Related]
42. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. Liao J, Zhang R, Qian H, Cao L, Zhang Y, Xu W, Li J, Wu M, Yin Z. Biochem Biophys Res Commun; 2012 Apr 06; 420(2):308-14. PubMed ID: 22425980 [Abstract] [Full Text] [Related]
43. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741 [Abstract] [Full Text] [Related]
44. Distinct urinary metabolic profile of human colorectal cancer. Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W. J Proteome Res; 2012 Feb 03; 11(2):1354-63. PubMed ID: 22148915 [Abstract] [Full Text] [Related]
45. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y. Am J Gastroenterol; 2006 Sep 03; 101(9):2038-43. PubMed ID: 16848811 [Abstract] [Full Text] [Related]
46. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS. Bowers J, Hughes E, Skill N, Maluccio M, Raftery D. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep 01; 966():154-62. PubMed ID: 24666728 [Abstract] [Full Text] [Related]
47. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Zhang J, Yan L, Chen W, Lin L, Song X, Yan X, Hang W, Huang B. Anal Chim Acta; 2009 Sep 14; 650(1):16-22. PubMed ID: 19720167 [Abstract] [Full Text] [Related]
48. [Recent development of the application of metabolomics in liver diseases]. Niu LL, Niu JQ. Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 14; 20(8):634-5. PubMed ID: 23227536 [No Abstract] [Full Text] [Related]
49. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Gao H, Lu Q, Liu X, Cong H, Zhao L, Wang H, Lin D. Cancer Sci; 2009 Apr 14; 100(4):782-5. PubMed ID: 19469021 [Abstract] [Full Text] [Related]
50. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry. Tsutsui H, Maeda T, Toyo'oka T, Min JZ, Inagaki S, Higashi T, Kagawa Y. J Proteome Res; 2010 Aug 06; 9(8):3912-22. PubMed ID: 20557141 [Abstract] [Full Text] [Related]